GlassScriptPhysician profile
Ramesh C Ghanta
NPI 1205821071
$1,676.86
in general payments reported to CMS, 2019-2025
16 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $31.01 · 2021: $11.21 · 2022: $320 · 2023: $374 · 2024: $105 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $779.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $446.12 | 2019-2025 | Rexulti, Abilify Maintena |
| Abbvie INC. | $273.37 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $243.45 | 2019-2023 | Spravato |
| Axsome Therapeutics, INC. | $213.38 | 2024-2025 | Auvelity |
| Allergan, INC. | $129.25 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $109.42 | 2019-2025 | Uzedy |
| Neuronetics, INC. | $95.16 | 2019 | |
| Vanda Pharmaceuticals INC. | $35.53 | 2020-2025 | Hetlioz, Fanapt |
| Takeda Pharmaceuticals U.S.A., INC. | $26.84 | 2019 | |
| Lundbeck LLC | $25.00 | 2019 | |
| Corium, LLC | $15.65 | 2022 | |
| Alkermes, INC. | $14.51 | 2022 | |
| Neurocrine Biosciences, INC. | $13.49 | 2022 | |
| Shire North American Group INC | $13.28 | 2019 | |
| Supernus Pharmaceuticals, INC. | $11.21 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramesh Ghanta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.